How do you pay?

How to pay the least

Ask for the cash price

Beqalzi

We didn’t find one.

What to do

  1. Ask your pharmacy for Beqalzi’s cash price, and one or two other pharmacies too.

Compare every option

Brand name

Beqalzi, the original

Cash priceAsk the pharmacy

We didn’t find a savings card or cash price from Beqalzi’s maker. Ask the pharmacy for Beqalzi’s cash price. With insurance, ask what your plan charges.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

We didn’t find one.

Not soldNone found

What it’s used for

What the FDA label says

BEQALZI is a BCL-2 inhibitor indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a Bruton's tyrosine kinase (BTK) inhibitor.

This indication is approved under accelerated approval based on response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).

Source: the FDA label for Beqalzi (BeOne Medicines USA, Inc.), September 25, 2026. Full label on DailyMed 

Good to know

  • We didn’t find a savings card from Beqalzi’s maker.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.